Kintegral Advisory’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $899K | Sell |
4,109
-6
| -0.1% | -$1.31K | 0.08% | 183 |
|
|
2025
Q1 | $921K | Sell |
4,115
-13
| -0.3% | -$2.91K | 0.09% | 183 |
|
|
2024
Q4 | $1.35M | Sell |
4,128
-192
| -4% | -$62.9K | 0.13% | 155 |
|
|
2024
Q3 | $1.3M | Sell |
4,320
-57
| -1% | -$17.1K | 0.12% | 161 |
|
|
2024
Q2 | $1.44M | Sell |
4,377
-6,736
| -61% | -$2.22M | 0.14% | 149 |
|
|
2024
Q1 | $4.4M | Sell |
11,113
-35
| -0.3% | -$13.9K | 0.44% | 62 |
|
|
2023
Q4 | $3.93M | Sell |
11,148
-71
| -0.6% | -$25K | 0.43% | 61 |
|
|
2023
Q3 | $4.21M | Sell |
11,219
-7
| -0.1% | -$2.63K | 0.52% | 55 |
|
|
2023
Q2 | $4.29M | Hold |
11,226
| – | – | 0.51% | 55 |
|
|
2023
Q1 | $3.89M | Sell |
11,226
-603
| -5% | -$209K | 0.5% | 59 |
|
|
2022
Q4 | $2.78M | Buy |
+11,829
| New | +$2.78M | 0.37% | 91 |
|